16
Participants
Start Date
April 15, 2020
Primary Completion Date
December 10, 2021
Study Completion Date
December 10, 2021
JBPOS0101
JBPOS0101 (investigational product)
The Children's Hospital of Philadelphia (CHOP), Philadelphia
Virginia Commonwealth University, Richmond
Duke University Medical Center, Durham
Center for Rare Neurological Diseases, Norcross
Pediatric Neurology, PA, Winter Park
Nicklaus Children's Hospital, Miami
University of Louisville School of Medicine, Louisville
Kyungpook National University Chilgok Hospital (KNUH), Daegu
Cleveland Clinic, Cleveland
Pusan National University Yangsan Hospital, Pusan
Mayo Clinic, Rochester
Arkansas Children's Hospital, Little Rock
Texas Children's Hospital, Houston
Children's Hospital Colorado, Aurora
Children's Hospital LA, Los Angeles
UCLA - David Geffen School of Medicine, Los Angeles
UCSF Epilepsy Center, San Francisco
Oregon Health and Science University, Portland
Multicare Institute for Research and Innovation, Tacoma
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
Bio-Pharm Solutions Co., Ltd.
INDUSTRY